AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2022
Jan 4, 2022
284_dirs_2022-01-04_f4ade66f-e8ce-4920-9d09-f4572b045ee8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2021-12-31
Reporting Person: Coe Mary Ellen (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | Phantom Stock | $ | A | 424.0605 | Acquired | Common Stock (424.0605) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10 | Direct |
Footnotes
F1: 1-for-1
F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
F3: Holdings include shares acquired in dividend reinvestment transactions.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30